Gut: The Inside Story of Our Body's Most Underrated Organ (Revised Edition)

Home > Other > Gut: The Inside Story of Our Body's Most Underrated Organ (Revised Edition) > Page 23
Gut: The Inside Story of Our Body's Most Underrated Organ (Revised Edition) Page 23

by Giulia Enders


  YOU MAY SOMETIMES see little bubbles of gas rising through the liquid as the fermentation process progresses. This is why people in ancient cultures, who had no knowledge of the microbial world, would sometimes dance around the fermentation vats, as they thought this would encourage the vegetables to bubble. Others, by contrast, would afford the barrels calm so as not to disturb the gods in their work. Once fermentation is complete and everything is ready, the result should taste sour, and should not be slimy in consistency or taste too strongly of alcohol. From this stage, it can be kept in the fridge.

  Incidentally, it is at this stage that the sauerkraut you buy from the supermarket is boiled to pasteurize it. This not only kills off the bacteria, but it also destroys some of the vitamin C they have produced. Manufacturers therefore often add vitamin C powder after pasteurization. The acid it relies on means that fermentation is the safest way to preserve food—canned or bottled foods have been known to cause illness due to temperature-resistant bacteria, but no case of illness caused by fermented foods has ever been reported.

  You can now add a spoon or two of your homemade sauerkraut or sour carrots to just about any meal: in salad instead of vinegar, on a burger instead of gherkin pickled in vinegar, in soups and stews (add just before serving), with vegetable or rice dishes, or, for those feeling particularly adventurous, with some honey in your breakfast porridge. Then just wait and see if you start craving this special “sourness” more and more. When your appetite decides it likes something after trying it once or twice—you might as well go with it.

  Acknowledgments

  THIS BOOK WOULD not exist if it weren’t for my sister, Jill. Without your free, rational, and inquisitive mind, I would have been stuck many times in a world where obedience and conformity are easier than courage and the will to make necessary mistakes. Although you lead a busy life yourself, you were always there, ready to go through my texts with me and inspire me with new ideas. You taught me how to work creatively. Whenever I feel bad, I remember we are made of the same stuff and each of us uses her talents differently. I would like to thank Ambrosius, who shielded me from too much work with a protective arm. I would also like to thank my family and my godfather for surrounding me like a forest surrounds a tree, keeping me rooted even when strong winds are blowing. I also thank Ji-Won for keeping me nourished so often during the writing of this book—with food and her wonderful nature. My thanks go to Anne-Claire and Anne for their help with even the trickiest of questions!

  I thank Michaela and Bettina, without whose sharp minds the writing of this book would never have come about. If it weren’t for my medical studies I would never have had the knowledge necessary to write this book, so I thank all my good teachers and professors, as well as the German state, which pays for my university studies. To everyone who has contributed their hard work to the realization of this book—from press officers, publishers, manufacturers, printers, marketers, proofreaders, booksellers, postal workers, to those of you reading this now: Thank you!

  References

  THIS LIST MAINLY contains references to sources dealing with content not normally covered in the standard text books.

  Part One

  BANDANI, A.R.: “EFFECT of Plant a-Amylase Inhibitors on Sunn Pest, Eurygaster Integriceps Puton (Hemiptera: Scutelleridae), Alpha-Amylase Activity.” In: Commun Agric Appl Biol Sci. 2005; 70 (4): pp. 869–873.

  Baugh, R.F. et al.: “Clinical Practice Guideline: Tonsillectomy in Children.” In: Otolaryngol Head Neck Surg. 2011 January; 144 (Suppl. 1): pp. 1–30.

  Bengmark, S.: “Integrative Medicine and Human Health—The Role of Pre-, Pro- and Synbiotics.” In: Clin Transl Med. 2012 May 28; 1 (1): p. 6.

  Bernardo, D et al.: “Is Gliadin Really Safe for Non-Coeliac Individuals? Production of Interleukin 15 in Biopsy Culture from Non-Coeliac Individuals Challenged with Gliadin Peptides.” In: Gut. 2007 June; 56 (6): p. 889 f.

  Bodinier, M. et al.: “Intestinal Translocation Capabilities of Wheat Allergens Using the Caco-2 Cell Line.” In: J Agric Food Chem. 2007 May 30; 55 (11): pp. 4576–4583.

  Bollinger, R. et al.: “Biofilms in the Large Bowel Suggest an Apparent Function of the Human Vermiform Appendix.” In: J Theor Biol. 2007 December 21; 249 (4): pp. 826–831.

  Catassi, C. et al.: “Non-Celiac Gluten Sensitivity: The New Frontier of Gluten Related Disorders.” In: Nutrients. 2013 September 26; 5 (10): pp. 3839–3853.

  Kim, B.H.; Gadd, G.M.: Bacterial Physiology and Metabolism. Cambridge: Cambridge University Press, 2008.

  Klausner, A.G. et al.: “Behavioral Modification of Colonic Function. Can Constipation Be Learned?” In: Dig Dis Sci. 1990 October; 35 (10): pp. 1271–1275.

  LAMERS, K.L. et al.: “Gliadin Induces an Increase in Intestinal Permeability and Zonulin Release by Binding to the Chemokine Receptor CXCR3.” In: Gastroenterology. 2008 July; 135 (1): pp. 194–204.

  LEDOCHOWSKI, M. ET al.: “Fructose- and Sorbitol-Reduced Diet Improves Mood and Gastrointestinal Disturbances in Fructose Malabsorbers.” In: Scand J Gastroenterol. 2000 October; 35 (10): pp. 1048–1052.

  LEWIS, S.J.; HEATON, K.W.: “Stool Form Scale as a Useful Guide to Intestinal Transit Time.” In: Scand J Gastroenterol. 1997 September; 32 (9): pp. 920–924.

  MARTÍN-PELÁEZ, S. ET al.: “Health Effects of Olive Oil Polyphenols: Recent Advances and Possibilities for the Use of Health Claims.” In: Mol. Nutr. Food Res. 2013; 57 (5): pp. 760–771.

  PAUL, S.: Paläopower—Das Wissen der Evolution nutzen für Ernährung, Gesundheit und Genuss. Munich: C.H. Beck-Verlag, 2013 (2nd Edition). (In German)

  SIKIROV, D.: “ETIOLOGY and Pathogenesis of Diverticulosis Coli: A New Approach.” In: Med Hypotheses. 1988 May: 26 (1): pp. 17–20.

  SIKIROV, D.: “COMPARISON of Straining during Defecation in Three Positions: Results and Implications for Human Health.” In: Dig Dis Sci. 2003 July; 48 (7): pp. 1201–1205.

  THORLEIFSDOTTIR, R.H. et al.: “Improvement of Psoriasis after Tonsillectomy Is Associated with a Decrease in the Frequency of Circulating T Cells That Recognize Streptococcal Determinants and Homologous Skin Determinants.” In: J Immunol. 2012; 188 (10): pp. 5160–5165.

  VAREA, V. et al.: “Malabsorption of Carbohydrates and Depression in Children and Adolescents.” In: J Pediatr Gastroenterol Nutr. 2005 May; 40 (5): pp. 561–565.

  WISNER, A. et al.: “Human Opiorphin, a Natural Antinociceptive Modulator of Opioid-Dependent Pathways.” In: Proc Natl Acad Sci USA. 2006 November 21; 103 (47): pp. 17979–17984.

  Part Two

  AGUILERA, M. ET al.: “Stress and Antibiotics Alter Luminal and Wall-Adhered Microbiota and Enhance the Local Expression of Visceral Sensory-Related Systems in Mice.” In: Neurogastroenterol Motil. 2013 August; 25 (8): pp. e515–e529.

  BERCIK, P. ET al.: “The Intestinal Microbiota Affect Central Levels of Brain-Derived Neurotropic Factor and Behavior in Mice.” In: Gastroenterology. 2011 August; 141 (2): pp. 599–609.

  BRAVO, J.A. ET al.: “Ingestion of Lactobacillus Strain Regulates Emotional Behavior and Central GABA Receptor Expression in a Mouse via the Vagus Nerve.” In: Proc Natl Acad Sci USA. 2011 September 20; 108 (38): pp. 16050–16055.

  BUBENZER, R.H.; KADEN, M.: at www.sodbrennen-welt.de (retrieved October 2013).

  CASTRÉN, E.: “NEURONAL Network Plasticity and Recovery from Depression.” In: JAMA Psychiatry. 2013: 70 (9): pp. 983–989.

  CRAIG, A.D.: “How Do You Feel—Now? The Anterior Insula and Human Awareness.” In: Nat Rev Neurosci. 2009 January; 10 (1): pp. 58–70.

  ENCK, P. ET al.: “Therapy Options in Irritable Bowel Syndrome.” In: Eur J Gastroenterol Hepatol. 2010 December; 22 (12): pp. 1402–1411.

  FURNESS, J.B. ET al.: “The Intestine as a Sensory Organ: Neural, Endocrine, and Immune Responses.” In: Am J Physiol Gastrointest Liver Physiol. 1999; 227 (5): pp. G922–G928.

  HUERTA-FRANCO, M.R. ET al.: “Effect of Psychological Stress on Gastric Motility Assessed by Electrical Bio-Impedance.” In: World J Gastroenterol.
2012 September 28; 18 (36): pp. 5027–5033.

  KELL, C.A. ET al.: “The Sensory Cortical Representation of the Human Penis: Revisiting Somatotopy in the Male Homunculus.” In: J Neurosci. 2005 June 22; 25 (25): pp. 5984–5987.

  KELLER, J. ET al.: “S3-Leitline der Deutschen Gesellschaft für Verdauungs-und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Neurogastroenterologie und Motilität (DGNM) zu Definition, Pathophysiologie, Diagnostik und Therapie intestinaler Motilitätsstörungen” [S3 Guidelines of the German Society for Digestive and Metabolic Diseases (DGVS) and the German Society for Neurogastroenterology and Motility (DGNM) for the Definition, Pathophysiology, Diagnosis, and Treatment of Intestinal Motility Disorders]. In: Z Gastroenterol. 2011; 49: pp. 374–390. (In German)

  KEYWOOD, C. ET al.: “A Proof of Concept Study Evaluating the Effect of ADX10059, a Metabotropic Glutamate Receptor-5 Negative Allosteric Modulator, on Acid Exposure and Symptoms in Gastro-Oesophageal Reflux Disease.” In: Gut. 2009 September; 58 (9): pp. 1192–1199.

  KRAMER, H. ET al.: “Tabuthema Obstipation: Welche Rolle spielen Lebensgewohnheiten, Ernährung, Prä- und Probiotika sowie Laxanzien?” [Taboo Subject Constipation: What Part Do Habits, Diet, Pre- and Probiotics, and Laxatives Play?]. In: Aktuelle Ernährungsmedizin. 2009; 34 (1): pp. 38–46. (In German)

  LAYER, P. ET al.: “S3-Leitlinie Reizdarmsyndrom: Definition, Pathophysiologie, Diagnostik und Therapie. Gemeinsame Leitlinie der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Neurogastroenterologie und Motilität (DGNM)” [S3 Guideline on Irritable Bowel Syndrom: Joint Guideline of the German Society for Digestive and Metabolic Diseases (DGVS) and the German Society for Neurogastroenterology and Motility (DGNM)]. In: Z Gastroenterol. 2011; 49: pp. 237–293. (In German)

  MA, X. et al.: “Lactobacillus Reuteri Ingestion Prevents Hyperexcitability of Colonic DRG Neurons Induced by Noxious Stimuli.” In: Am J Physiol Gastrointest Liver Physiol. 2009 April; 296 (4): pp. G868–G875.

  MAYER, E.A.: “GUT Feelings: The Emerging Biology of Gut-Brain Communication.” In: Nat Rev Neurosci. 2011 July 13; 12 (8): pp. 453–466.

  MAYER, E.A. ET al.: “Brain Imaging Approaches to the Study of Functional GI Disorders: A Rome Working Team Report.” In: Neurogastroenterol Motil. 2009 June; 21 (6): pp. 579–596.

  MOSER, G. (Ed.): Psychosomatik in der Gastroenterologie und Hepatologie [Psychosomatics in Gastroenterology and Hepatology]. Vienna; New York: Springer, 2007. (In German)

  NALIBOFF, B.D. ET al.: “Evidence for Two Distinct Perceptual Alterations in Irritable Bowel Syndrom.” In: Gut. 1997 October; 41 (4): pp. 505–512.

  PALATTY, P.L. ET al.: “Ginger in the Prevention of Nausea and Vomiting: A Review.” In: Crit Rev Food Sci Nutr. 2013; 53 (7): pp. 659–669.

  REVEILLER, M. ET al.: “Bile Exposure Inhibits Expression of Squamous Differentiation Genes in Human Esophageal Epithelial Cells.” In: Ann Surg. 2012 June; 255 (6): pp. 1113–1120.

  REVENSTORF, D.: Expertise zur wissenschaftlichen Evidenz der Hypnotherapie [Expert Opinion on the Scientific Evidence for Hypnotherapy]. Tübingen, 2003; at http://www.meg.tuebingen.de/downloads/Expertise.pdf (retrieved October 2013). (In German)

  SIMONS, C.C. ET al.: “Bowel Movement and Constipation Frequencies and the Risk of Colorectal Cancer among Men in the Netherlands Cohort Study on Diet and Cancer.” In: Am J Epidemiol. 2010 December 15; 172 (12): pp. 1404–1414.

  STREITBERGER, K. ET al.: “Acupuncture Compared to Placebo-Acupuncture for Postoperative Nausea and Vomiting Prophylaxis: A Randomised Placebo-Controlled Patient and Observer Blind Trial.” In: Anaesthesia. 2004 February; 59 (2): pp. 142–149.

  TILLISCH, K. ET al.: “Consumption of Fermented Milk Product with Probiotic Modulates Brain Activity.” In: Gastroenterology. 2013 June; 144 (7): pp. 1394–1401.

  Part Three

  AGGARWAL, J. ET al.: “Probiotics and their Effects on Metabolic Diseases: An Update.” In: J Clin Diagn Res. 2013 January; 7 (1): pp. 173–177.

  ARNOLD, I.C. ET al.: “Helicobacter pylori Infection Prevents Allergic Asthma in Mouse Models through the Induction of Regulatory T Cells.” In: J Clin Invest. 2011 August; 121 (8): pp. 3088–3093.

  Arumugam, M. ET al.: “Enterotypes of the Human Gut Microbiome.” In: Nature. 2011 May 12; 474 (7353); 1: pp. 174–180.

  BÄCKHED, F.: “ADDRESSING the Gut Microbiome and Implications for Obesity.” In: International Dairy Journal. 2012; 20 (4): pp. 259–261.

  BALAKRISHNAN, M.; FLOCH, M.H.: “Prebiotics, Probiotics and Digestive Health.” In: Curr Opin Clin Nutr Metab Care. 2012 November; 15 (6): pp. 580–585.

  BARROS, F.C.: “CESAREAN Section and Risk of Obesity in Childhood, Adolescence, and Early Adulthood: Evidence from 3 Brazilian Birth Cohorts.” In: Am J Clin Nutr. 2012; 95 (2): pp. 465–470.

  BARTOLOMEO, F. Di: “Prebiotics to Fight Diseases: Reality of Fiction?” In: Phytother Res. 2013 October; 27 (10): pp. 1457–1473.

  BISCHOFF, S.C.; KÖCHLING, K.: “Pro- und Präbiotika” [Pro- and Prebiotics]. In: Zeitschrift für Stoffwechselforschung, klinische Ernährung und Diätik. 2012; 37: pp. 287–304.

  BORODY, T.J. ET al.: “Fecal Microbiota Transplantation: Indications, Methods, Evidence, and Future Directions.” In: Curr Gastroenterol Rep. 2013; 15 (8): p. 337.

  BRÄUNIG, J.: Verbrauchertipps zu Lebensmittelhygiene, Reinigung und Desinfektion [Consumer Tips on Food Hygiene, Cleaning and Disinfection]. Berlin: German Federal Institute for Risk Assessment, 2005. (In German)

  BREDE C.: Das Instrument der Sauberkeit. Die Entwicklung der Massenproduktion von Feinseifen in Deutschland 1850 to 2000 [The Instrument of Cleanliness. The Development of Fine Soap Mass Production in Germany 1850 to 2000]. Münster et al.: Waxmann, 2005. (In German)

  CAPORASO, J.G. ET al.: “Moving Pictures of the Human Microbiome.” In: Genome Biol. 2011; 12 (5): p. R50.

  CARVALHO, B.M.; SAAD, M.J.: “Influence of Gut Microbiota on Subclinical Inflammation and Insulin Resistance.” In: Mediators Inflamm. 2013; 2013: 986734.

  CHARALAMPOPOULOS, D.; RASTALL, R.A.: “Prebiotics in Foods.” In: Current Opinion on Biotechnology. 2012, 23 (2): pp. 187–191.

  CHEN, Y. ET al.: “Association between Helicobacter pylori and Mortality in the NHANES I Study.” In: Gut. 2013 September; 62 (9): pp. 1262–1269.

  DEVARAJ, S. ET al.: “The Human Gut Microbiome and Body Metabolism: Implications for Obesity and Diabetes.” In: Clin Chem. 2013 April; 59 (4): pp. 617–628.

  DOMINGUEZ-BELLO, M.G. ET al.: “Development of the Human Gastrointestinal Microbiota and Insights from High-Throughput Sequencing.” In: Gastroenterology. 2011 May; 140 (6): pp. 1713–1791.

  DOUGLAS, L.C.; SANDERS, M.E.: “Probiotics and Prebiotics in Dietetics Practice.” In: J Am Diet Assoc. 2008 March; 108 (3): pp. 510–521.

  EPPINGER, M. ET al.: “Who Ate Whom? Adaptive Helicobacter Genomic Changes That Accompanied a Host Jump from Early Humans to Large Felines.” In: PLoS Genet. 2006 July; 2 (7): p. e120.

  FAHEY, J.W. ET al.: “Urease from Helicobacter pylori Is Inactivated by Sulforaphane and Other Isothiocyanates.” In: Biochem Biophys Res Commun. 2013 May 24; 435 (1): pp. 1–7.

  FLEGR, J.: “INFLUENCE of Latent Toxoplasma Infection on Human Personality, Physiology and Morphology: Pros and Cons of the Toxoplasma-Human Model in Studying the Manipulation Hypothesis.” In: J Exp Biol. 2013 January 1; 216 (Pt. 1): pp. 127–133.

  FLEGR, J. et al.: “Increased Incidence of Traffic Accidents in Toxoplasma-Infected Military Drivers and Protective Effect RhD Molecule Revealed by a Large-Scale Prospective Cohort Study.” In: BMC Infect Dis. 2009 May 26; 9: p. 72.

  FLINT, H.J.: “OBESITY and the Gut Microbiota.” In: J Clin Gastroenterol. 2011 November; 45 (Suppl.): pp. 128–132.

  FOUHY, F. ET al.: “High-Throughput Sequencing Reveals the Incomplete, Short-Term Recovery of Infant Gut Microbiota following Parenteral Antibiotic Treatment with Ampicillin and Gentamicin.” In: Antimicrob Agents Chemother. 2012 N
ovember; 56 (11): pp. 5811–5820.

  FUHRER, A. ET al.: “Milk Sialyllactose Influences Colitis in Mice through Selective Intestinal Bacterial Colonization.” In: J Exp Med. 2010 December 20; 207 (13): pp. 2843–2854.

  GALE, E.A.M.: “A Missing Link in the Hygiene Hypothesis?” In: Diabetologia. 2002; 45 (4): pp. 588–594.

  GANAL, S.C. ET al.: “Priming of Natural Killer Cells by Non-Mucosal Mononuclear Phagocytes Requires Instructive Signals from the Commensal Microbiota.” In: Immunity. 2012 July 27; 37 (1): pp. 171–186.

  GERMAN FEDERAL GOVERNMENT: “Antwort der Bundesregierung auf die Kleine Anfrage der Abgeordneten Friedrich Ostendorff, Bärbel Höhn, Nicole Maisch, weiterer Abgeordeter und der Fraktion BÜNDNIS 90/DIE GRÜNEN.” Drucksache 17/10017. “Daten zur Antibiotikavergabe in Nutztierhaltungen und zum Eintrag von Antibiotika und multiresistenten Keimen in die Umwelt.” Drucksache 17/10313 [The German Federal Government’s response to the minor interpellation from members Friedrich Ostendorff, Bärbel Höhn, Nicole Maisch, other members, and the ALLIANCE 90/THE GREENS parliamentary group—Parliamentary record 17/10017. Data on the use of antibiotics in livestock farming and the contamination of the environment by antibiotics and multidrug resistant bacteria. Parliamentary record 17/10313], 17 July 2012, at http://dip21.bundestag.de/dip21/btd/17/103/1710313.pdf (retrieved October 2013). (In German)

  GIBNEY, M.J.; BURSTYN, P.G.: “Milk, Serum Cholesterol, and the Maasai—A Hypothesis.” In: Atherosclerosis. 1980; 35 (3): pp. 339–343.

 

‹ Prev